The transformation of EGFR-mutant LUAD to SCLC (referred to as SCLC transformation or lineage transformation) accounts for up to 14% of acquired resistance to EGFR TKIs (Sequist et al., 2011). The gene discussed is EGFR; the disease is small cell lung carcinoma.